Lab-Grown Mini-Tumors could predict best prostate cancer therapy

NCT ID NCT07004582

Recruiting now Knowledge-focused Sponsor: Maastricht Radiation Oncology Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study aims to improve treatment for aggressive prostate cancer by growing 3D mini-tumors from patient samples in the lab. Researchers will compare two techniques to see which better predicts how a patient's cancer will respond to radiation or drugs. The goal is to help doctors choose the right treatment faster, especially for men with high-risk or metastatic disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors choose the most effective treatment for each patient with aggressive prostate cancer, potentially improving survival and reducing unnecessary side effects.
What could go wrong: This is an early-stage lab study, not a treatment trial. The techniques may not work for all tumor types, and lab results may not perfectly predict real patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hormone-resistant prostate carcinoma metastatic prostate carcinoma Neoplasm Metastasis prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED PROSTATE CANCER PROSTATE CANCER PROSTATE CANCER - RECURRENT PROSTATE CANCER METASTATIC DISEASE

Contacts and locations

Locations

Academisch Ziekenhuis Maastricht
NOT_YET_RECRUITING

Maastricht, Limburg, 6229 ET, Netherlands
Maastricht Radiation Oncology
RECRUITING

Maastricht, Limburg, 6229 ET, Netherlands
Zuyderland Medisch Centrum
NOT_YET_RECRUITING

Heerlen, Limburg, 6419 PC, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.